C., & Gautam, G
It is important to appreciate, however, that the increased risk relates to a disorder that is relatively uncommon. He went on to say: Our findings should be viewed as being significant but tentative, as future studies are needed to examine these questions in a much larger and more diverse population
Purge or Damage
14 However, in two studies that included participants not enrolled in the SURPASS and SURMOUNT studies, ie, a large number of individuals who switched from other GLP-1 RAs to tirzepatide, those who transitioned from semaglutide experienced greater weight loss with tirzepatide treatment
Wegovy: disponibile in Italia da inizio 2024 in diverse formulazioni (0,25 mg, 0,5 mg, 1 mg, fino a 2,4 mg)
Adipose tissue, particularly visceral fat, is metabolically active and secretes pro-inflammatory adipokines